Top Markets
Coin of the day
EssilorLuxottica S.A. EssilorLuxottica S.A.

EssilorLuxottica S.A.

EL
Rankning i aktier #321
EssilorLuxottica S.A., established in Paris, France, in 1849, is a global... EssilorLuxottica S.A., established in Paris, France, in 1849, is a global enterprise dedicated to the design, production, and distribution of a wide range of ophthalmic products, including corrective lenses, eyewear frames, and sunglasses. The company extends its reach across North America, Europe, Latin America, Asia, Oceania, and Africa. Its operations are structured into five key divisions: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale division handles the manufacturing and large-scale distribution of luxury and performance eyewear. Conversely, the Retail segment is responsible for the direct sale of these premium and athletic vision products to consumers. The Lenses and Optical Instruments segment offers an extensive portfolio of advanced lens technologies, including Varilux progressive lenses, Crizal anti-reflective and anti-smudge coatings, Transitions photochromic lenses (featuring the latest Signature Gen 8), Eyezen lenses optimized for digital screen users, and Xperio polarized sun lenses, alongside corrective lens brands under license such as Nikon and Kodak. This segment also provides essential equipment like lens edging and mounting tools for opticians and laboratories, as well as optometry instruments for eye care professionals, educational bodies, military, and other organizations, while also developing digital platforms for online optical sales. The Equipment division supplies sophisticated digital surfacing and lens coating machinery to prescription laboratories, integrated optical networks, and lens manufacturers worldwide. Finally, the Sunglasses and Readers segment focuses on non-prescription eyewear, offering a diverse collection of sunglasses and reading glasses through various owned brands like Foster Grant, Magnivision, and Ryders Eyewear; licensed brands including Reebok, Steve Madden, Marvel, and Disney; and regional labels such as Bolon and Mujosh. EssilorLuxottica maintains a substantial operational network, encompassing 490 prescription laboratories and edging-mounting facilities. The company, initially known as Essilor International Société Anonyme, adopted its current name in October 2018.
Aktiekurs
$164.10
Senast synkroniserad: 2026-09-18
Marknadsvärde
$75.42B
Förändring (1 dag)
-2.19%
Förändring (1 år)
-48.95%
Land
FR
Handel EssilorLuxottica S.A. (EL)

Kategori

P/E-tal för EssilorLuxottica S.A. (EL)
P/E-tal per September 2026 TTM: 27.35
Enligt EssilorLuxottica S.A. senaste finansiella rapporter och aktiekurs är det aktuella P/E-talet (TTM) 27.35. I slutet av 2023 hade företaget ett P/E-tal på 35.53.
Historik för P/E-tal för EssilorLuxottica S.A. från 2001 till 2026
P/E-tal vid slutet av varje år
År P/E-tal Ändra
2026 (TTM) 27.35 -39.66%
2024 45.33 27.59%
2023 35.53 2.23%
2022 34.76 -38.75%
2021 56.74 -91.32%
2020 654.06 1,094.97%
2019 54.73 105.86%
2018 26.59 -17.25%
2017 32.13 13.38%
2016 28.34 -12.14%
2015 32.25 53.58%
2014 21.00 -23.32%
2013 27.39 1.02%
2012 27.11 21.25%
2011 22.36 2.32%
2010 21.85 -1.06%
2009 22.09 21.61%
2008 18.16 -25.82%
2007 24.49 -8.63%
2006 26.80 4.31%
2005 25.69 0.97%
2004 25.44 38.75%
2003 18.34 -6.98%
2002 19.71 -1.88%
2001 20.09 0.00%
P/E-tal för liknande företag eller konkurrenter
Företag P/E-tal Skillnad i P/E-tal Land
42.71 56.13%
US
55.09 101.42%
US
- -
JP
- -
CH
- -
US
Hur man läser ett P/E-tal

P/E-talet (Price/Earnings) mäter förhållandet mellan ett företags aktiekurs och dess vinst per aktie.
Ett lågt men positivt P/E visar ett företag med hög vinst i förhållande till värderingen och kan vara undervärderat. Ett högt negativt (nära 0) P/E indikerar stora förluster.

Företag med P/E över 30 eller negativt ses ofta som "tillväxtaktier", vilket innebär att investerare förväntar sig tillväxt eller framtida lönsamhet.

Företag med positivt P/E under 10 ses som "värdeaktier" och är redan lönsamma men med begränsad tillväxtpotential.